The report analyzes development strategies for 347 colorectal cancer drugs in different stages of development. The analysis looks at drug targets and drug target strategies.
Related Articles on Drug Development:
MIT Researcher: Device and Drug Combos Carry Greater Risk, Reward
USC School of Pharmacy Establishes International Center for Regulatory Science
FDA Reports Increase in New Drug Approvals in FY 2011
